Google DeepMind Prepares for First Human Trials of AI-Designed Drugs
TL;DR Summary
Google DeepMind's affiliate, Isomorphic Labs, is preparing to begin human trials of AI-designed drugs, aiming to revolutionize drug development by increasing success rates and reducing costs, leveraging breakthroughs like AlphaFold for protein modeling.
Topics:top-news#ai-drug-discovery#alphafold#clinical-trials#deepmind#health-and-technology#isomorphic-labs
- Google DeepMind has grand ambitions to 'cure all diseases' with AI. Now, it's gearing up for its first human trials Fortune
- Alphabet's Isomorphic Labs to Launch Human Trials for AI-Designed Drugs AInvest
- Google DeepMind is ready to start human trials of AI-designed drugs; company exec says, ‘We’re getting ve Times of India
- Google DeepMind to soon begin human trials of AI-designed drugs NewsBytes
- Google DeepMind has grand ambitions to ‘cure all diseases’ with AI. Now, it’s gearing up for its first human trials Yahoo
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
2 min
vs 3 min read
Condensed
94%
524 → 33 words
Want the full story? Read the original article
Read on Fortune